INDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections

J Drugs Dermatol. 2024 Nov 1;23(11):43661s3-43661s14.

Abstract

We evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide diaminobutyroyl, 5% polyhydroxy acids (PHA), 5% niacinamide, and 1% laminaria extract (topical neuro-peptide serum [TNP-serum]). The TNP-serum works synergistically by stimulating 9 key skin biomarkers to reduce wrinkles and produce a skin-brightening effect. Here, we highlight the real-life experiences of 5 dermatologists and 2 surgeons, using an integrated skincare regimen consisting of botulinum toxin type-A (BTX-A) injection in conjunction with twice daily TNP-serum. Real-world cases provide evidence for combination treatments that may be used in cosmetic dermatology to improve patient outcomes and satisfaction. TNP-serum appears to complement BTX-A injections to improve radiance, reduce fine lines, and reduce wrinkles in diverse patients. Incorporating TNP-serum into integrated skincare regimens may offer an additive effect to BTX-A injections and, ultimately, optimize patient results. J Drugs Dermatol. 2024;23:11(Suppl 2):s3-14.

MeSH terms

  • Adult
  • Botulinum Toxins, Type A* / administration & dosage
  • Cosmetic Techniques
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Agents / administration & dosage
  • Niacinamide / administration & dosage
  • Oligopeptides
  • Patient Satisfaction
  • Skin Aging* / drug effects
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A
  • Niacinamide
  • acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide
  • Neuromuscular Agents
  • Oligopeptides